A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Cysteamine
DPDPE
The risk or severity of adverse effects can be increased when Clomipramine is combined with DPDPE.
Cysteamine
Serotonin
The risk or severity of adverse effects can be increased when Clomipramine is combined with Serotonin.
Cysteamine
Cinitapride
The risk or severity of adverse effects can be increased when Clomipramine is combined with Cinitapride.
Cysteamine
Sulthiame
The risk or severity of adverse effects can be increased when Clomipramine is combined with Sulthiame.
Cysteamine
Wortmannin
The risk or severity of adverse effects can be increased when Clomipramine is combined with Wortmannin.
Cysteamine
Mebutamate
The risk or severity of adverse effects can be increased when Clomipramine is combined with Mebutamate.
Cysteamine
Triclofos
The risk or severity of adverse effects can be increased when Clomipramine is combined with Triclofos.
Cysteamine
Fospropofol
The risk or severity of adverse effects can be increased when Clomipramine is combined with Fospropofol.
Cysteamine
Nitrous oxide
The risk or severity of adverse effects can be increased when Clomipramine is combined with Nitrous oxide.
Cysteamine
Saredutant
The risk or severity of adverse effects can be increased when Clomipramine is combined with Saredutant.
Cysteamine
Gaboxadol
The risk or severity of adverse effects can be increased when Clomipramine is combined with Gaboxadol.
Cysteamine
Ocinaplon
The risk or severity of adverse effects can be increased when Clomipramine is combined with Ocinaplon.
Cysteamine
Tramiprosate
The risk or severity of adverse effects can be increased when Clomipramine is combined with Tramiprosate.
Cysteamine
Tolperisone
The risk or severity of adverse effects can be increased when Clomipramine is combined with Tolperisone.
Cysteamine
YKP-1358
The risk or severity of adverse effects can be increased when Clomipramine is combined with YKP-1358.
Cysteamine
Gantacurium
The risk or severity of adverse effects can be increased when Clomipramine is combined with Gantacurium.
Cysteamine
PRX-08066
The risk or severity of adverse effects can be increased when Clomipramine is combined with PRX-08066.
Cysteamine
Naluzotan
The risk or severity of adverse effects can be increased when Clomipramine is combined with Naluzotan.
Cysteamine
Naronapride
The risk or severity of adverse effects can be increased when Clomipramine is combined with Naronapride.
Cysteamine
Tetrodotoxin
The risk or severity of adverse effects can be increased when Clomipramine is combined with Tetrodotoxin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3